PGE 2 alters chromatin through H2A.Z-variant enhancer nucleosome modification to promote hematopoietic stem cell fate
Proceedings of the National Academy of Sciences · 09.05.2023 · 120 (19)
DOI: 10.1073/pnas.2220613120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023-05. Verfasst von Audrey Sporrij und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138. Hauptthemen laut MEDLINE: Nucleosomes, Histones. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NHLBI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Prostaglandin E2 (PGE 2 ) and 16,16-dimethyl-PGE 2 (dmPGE 2 ) are important regulators of hematopoietic stem and progenitor cell (HSPC) fate and offer potential to enhance stem cell therapies [C. Cutler et al. Blood 122 , 3074–3081(2013); W. Goessling et al. Cell Stem Cell 8 , 445–458 (2011); W. Goessling et al. Cell 136 , 1136–1147 (2009)]. Here, we report that PGE 2 -induced changes in chromatin at enhancer regions through histone-variant H2A.Z permit acute inflammatory gene induction to promote HSPC fate. We found that dmPGE 2 -inducible enhancers retain MNase-accessible, H2A.Z-variant nucleosomes permissive of CREB transcription factor (TF) binding. CREB binding to enhancer nucleosomes following dmPGE 2 stimulation is concomitant with deposition of histone acetyltransferases p300 and Tip60 on chromatin. Subsequent H2A.Z acetylation improves chromatin accessibility at stimuli-responsive enhancers. Our findings support a model where histone-variant nucleosomes retained within inducible enhancers facilitate TF binding. Histone-variant acetylation by TF-associated nucleosome remodelers creates the accessible nucleosome landscape required for immediate enhancer activation and gene induction. Our work provides a mechanism through which inflammatory mediators, such as dmPGE 2 , lead to acute transcriptional changes and modify HSPC behavior to improve stem cell transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138.
- Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115.
- Department of Molecular Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.
- Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA 02215.
- Oncode Institute, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht 3584 CT, The Netherlands.
- Princess Máxima Center for Pediatric Oncology, Utrecht 3584 CS, The Netherlands.
ORCID-Profile: Michael Y Tolstorukov, Hans Clevers, Leonard I Zon
Förderung
- NIH HHS
- NHLBI NIH HHS
- NIDDK NIH HHS
- HHS | NIH | National Heart, Lung, and Blood Institute
Zitieren
APA
Sporrij, A., Choudhuri, A., Prasad, M., Muhire, B., Fast, E. M., Manning, M. E., Weiss, J. D., Koh, M., Yang, S., Kingston, R. E., Tolstorukov, M. Y., Clevers, H., & Zon, L. I. (2023). PGE 2 alters chromatin through H2A.Z-variant enhancer nucleosome modification to promote hematopoietic stem cell fate. Proceedings of the National Academy of Sciences, 120(19). https://doi.org/10.1073/pnas.2220613120
Vancouver
Sporrij A, Choudhuri A, Prasad M, Muhire B, Fast EM, Manning ME, et al. PGE 2 alters chromatin through H2A.Z-variant enhancer nucleosome modification to promote hematopoietic stem cell fate. Proceedings of the National Academy of Sciences. 2023;120(19). doi:10.1073/pnas.2220613120
BibTeX
@article{Sporrij2023,
author = {Sporrij, Audrey and Choudhuri, Avik and Prasad, Meera and Muhire, Brejnev and Fast, Eva M and Manning, Margot E and Weiss, Jodi D and Koh, Michelle and Yang, Song and Kingston, Robert E and Tolstorukov, Michael Y and Clevers, Hans and Zon, Leonard I},
title = {PGE 2 alters chromatin through H2A.Z-variant enhancer nucleosome modification to promote hematopoietic stem cell fate},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
volume = {120},
number = {19},
doi = {10.1073/pnas.2220613120}
}
EUVIMED